WHAT YOU NEED TO KNOW
- Haile McAnally says abortion pills caused severe bleeding that required a blood transfusion 14 years ago.
- SBA Pro-Life America wants Robert F. Kennedy Jr. to restore in person dispensing requirements during the FDA safety review.
- An April 2025 study found that 10.93% of women experienced a serious adverse event within 45 days after a mifepristone abortion.
- The group argues Kennedy has legal authority to suspend drug approvals that present an imminent public health hazard.
A woman who says abortion pills nearly killed her is urging Health and Human Services Secretary Robert F. Kennedy Jr. to crack down on mail order access, warning that shipping the drugs directly to homes is reckless and could endanger more women.
Haile McAnally said she experienced severe bleeding and needed a blood transfusion after taking abortion pills 14 years ago. She spoke out after a Nov. 6 letter from Susan B. Anthony Pro-Life America called for immediate federal action.
The organization asked Kennedy to restore in person dispensing requirements for mifepristone while the Food and Drug Administration conducts a safety review of the drug.
“Mailing them across the country to doorsteps just as easily as you could an Amazon package is not only reckless, it puts a lot of women's lives and safety at risk,” McAnally told Fox News Digital.
McAnally is communications director for the Nebraska Republican Party and works with SBA Pro-Life America on legislation. She previously described her experience with abortion pills to Fox News Digital in September.
“I had my own run-in with abortion pills 14 years ago,” McAnally said. “When I took these pills at a clinic and ended up having severe side effects, I wound up alone in my bathtub, almost dying from these pills, needing a blood transfusion at the hospital.”
Mifepristone blocks progesterone, a hormone needed to sustain pregnancy, and is followed by misoprostol to complete the abortion process. Kennedy oversees the FDA, which is reviewing mifepristone safety.
An April 2025 study conducted by the conservative Ethics and Public Policy Center found that 10.93% of women “experience sepsis, infection, hemorrhaging, or another serious adverse event within 45 days following a mifepristone abortion.”
SBA Pro-Life America argued in its letter that Kennedy has legal authority to suspend certain drug approvals immediately if he determines that they pose an imminent threat to public health. McAnally said she wants stronger oversight of the drug.
“I just continue to urge the federal government, especially RFK Jr. and the senators … to make sure that we really think about the ramifications of letting this go through so easily,” she said.
McAnally said women and their safety must be placed first rather than treated callously. She described life as precious and said women’s safety deserves the utmost importance when addressing the issue.
The group cited a Justice Department filing from earlier this year that it says confirms Kennedy could use his authority to reverse the Biden administration’s 2023 changes allowing mifepristone to be dispensed through the mail.
SBA Pro-Life America wants the requirement for in person dispensing restored while the FDA finishes its broader safety review. “Secretary Kennedy, you possess clear statutory authority to protect women from this growing form of abuse,” the letter reads.
The letter said federal law permits the HHS secretary to suspend approval of a drug application immediately upon finding an imminent hazard to public health. It argued that this authority would cover the 2023 changes to the Risk Evaluation and Mitigation Strategy for mifepristone.
The Trump administration’s reported decision to drop Heidi Overton’s nomination added complications to the regulatory debate. Erik Baptist, senior vice president of legal strategy at SBA Pro-Life America, said the group anticipated meeting the administration’s new nominee for FDA Commissioner.
“We hope to secure two fundamental commitments on abortion-drug policy before the Senate proceeds with any confirmation vote,” Baptist said. He called for an immediate end to the Biden FDA’s mail order abortion drug policy.
Baptist also said the FDA should improve its safety study by obtaining robust data, increasing transparency and inviting external experts to participate. “Confirmation is not a coronation. It is a time to vet nominees and seek commitments before they take office,” he added.
McAnally continued pressing for a halt to mail order abortion pills during the FDA review. “We're asking that we put a stop to these mail-order abortion drugs and not only for more research into mifepristone and the side effects, but just because the recklessness and the side effects that these have,” she said.
Join the Discussion
COMMENTS POLICY: We have no tolerance for messages of violence, racism, vulgarity, obscenity or other such discourteous behavior. Thank you for contributing to a respectful and useful online dialogue.